A research-intensive medical school pairing deep drug-discovery and AI capabilities with a prolific technology-transfer engine and dense industry-partnership network.
Deterministic scores · rules-based, not AIiHow these scores are obtained: each one is computed from this profile's listed attributes — capability checkboxes, certifications, capacity figures and coverage — by a fixed formula, recomputed on every page load. Deterministic and rules-based means the score comes from a fixed, transparent formula over listed attributes — the same inputs always produce the same score. It is not AI: there is no model, no learning, and no hidden weighting. Whether a score is relevant to you depends on your specific project: a capability that raises the number may not matter for your work, and a niche strength your project needs may barely move it. Capability scores are a directional starting point, not a verdict. A lower score does not disqualify a company or consultant, and no decision should rest on the score alone — always contact the company directly to confirm the specifics for your project.
Research excellence iBlends publication volume (tiers from 4 points for any output up to 34 at 50,000+ papers), patent count (3 to 22 points at 1,500+), citation impact (2 to 20 points at 80+), and how many of the 14 research capabilities the profile checks - 1.8 points each, capped at 24. Levels: 80+ World-leading | 60-79 Research-intensive | 40-59 Established | below 40 Emerging. Whether this dimension matters for you depends on your specific project.
24Emerging
Discovery capability iAdds points for six discovery checkboxes: drug discovery, target discovery, and AI drug discovery are 14 each; biomarker development, translational medicine, and gene editing are 12 each. Each research technology listed adds 2 more points, capped at 22. Levels: 80+ Pioneering | 60-79 Advanced | 40-59 Developing | below 40 Foundational. Whether this dimension matters for you depends on your specific project.
94Pioneering
Translational readiness iScores four checkboxes - translational medicine (24), clinical research (22), technology transfer (18), core facilities offered (14) - plus 4 points per facility listed on the profile, capped at 22. Levels: 80+ Clinic-ready | 60-79 Translational | 40-59 Bridging | below 40 Bench-focused. Whether this dimension matters for you depends on your specific project.
86Clinic-ready
Commercialization iCombines patent count (3 to 24 points at 1,000+), spin-out companies (3 to 22 points at 100+), industry partnerships (2 to 18 points at 200+), 14 points for a technology-transfer office, and 5 points per licensable technology listed, capped at 22. Levels: 80+ Highly translatable | 60-79 Strong pipeline | 40-59 Active | below 40 Early-stage. Whether this dimension matters for you depends on your specific project.
24Early-stage
Funding scale iUses active grant count (tiers from 4 points up to 32 at 2,000+ grants), total grant funding (6 points for any up to 40 at 1.5 billion USD or more), and funding-source diversity at 4 points per source listed, capped at 22. Levels: 80+ Exceptionally funded | 60-79 Well-funded | 40-59 Funded | below 40 Limited. Whether this dimension matters for you depends on your specific project.
20Limited
Infrastructure iMeasures scale: principal investigators (5 to 30 points at 1,500+), core-facility types listed (3.2 points each, capped at 26), facilities on the profile (4 points each, capped at 22), and employee count (3 to 22 points at 20,000+). Levels: 80+ Comprehensive | 60-79 Extensive | 40-59 Solid | below 40 Focused. Whether this dimension matters for you depends on your specific project.
44Solid
Research & discovery capabilities
Drug discoveryTarget discoveryBiomarker developmentTranslational medicineGene editing (CRISPR)AI drug discoveryGenomicsProteomicsSynthetic biologyOrganoidsTechnology transferSponsored researchCore facilities offeredClinical research
Research areas
AI drug discoverySynthetic biologyStem-cell biologyImmuno-oncology
Research-technology platforms
AI Drug DiscoveryMachine LearningCRISPRGenomicsSingle Cell SequencingSynthetic BiologyOrganoidsLab-on-Chip Systems
Therapeutic areas
OncologyImmunologyCardiovascularNeuroscienceCell therapyRegenerative medicine
Locations
Stanford, CA, USAHQPalo Alto, CA, USAClinical campus